"Graves' Disease (Overactive Thyroid) Market – Industry Trends and Forecast to 2029
Global Graves' Disease (Overactive Thyroid) Market, By Diagnosis (Radioactive Iodine Uptake, Imaging Tests, Blood Tests, Others), Treatment (Radioactive iodine therapy, Medication, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029
Data Bridge Market Research analyses that the Graves' disease (overactive thyroid) market was valued at USD 351.55 million in 2021 and is expected to reach USD 507.65 million by 2029, registering a CAGR of 4.70% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Access Full 350 Pages PDF Report @
https://www.databridgemarketresearch.com/reports/global-graves-disease-overactive-thyroid-market
Graves' disease (overactive thyroid), sometimes known as Basedow's disease, is an autoimmune condition that leads to hyperthyroidism. It occurs when the body's immune cells attack the thyroid, causing excessive thyroid hormone production. Graves' disease treatment aims to inhibit thyroid hormone production and block the hormones' effects on the body. Beta-blockers including propranolol and metoprolol are frequently used as first-line treatments. These medications help to keep your heart rate in check and safeguard it until other hyperthyroidism treatments take effect. Antithyroid drugs like methimazole (Tapazole) and propylthiouracil stop the thyroid gland from producing thyroid hormone. Radioiodine therapy entails taking a single dose of radioactive iodine in the form of a pill or a liquid. Radiation kills thyroid gland cells over a period of two to three months.
**Segments**
- **Diagnosis Type**: The Graves' Disease market can be segmented based on the type of diagnosis techniques utilized such as blood tests, imaging tests (like ultrasound or CT scans), and uptake scans to detect thyroid function.
- **Treatment Type**: This segment includes the various treatment options available for Graves' Disease, including medication therapy, radioactive iodine therapy, and surgery for the removal of the thyroid gland.
- **End-users**: The market can also be categorized based on the end-users such as hospitals, specialty clinics, diagnostic centers, and retail pharmacies where patients seek treatment and medication for Graves' Disease.
**Market Players**
- **Merck & Co., Inc.**: A leading player in the Graves' Disease market, Merck & Co., Inc. offers medications and therapies for thyroid disorders, including Graves' Disease.
- **Pfizer Inc.**: Another key player, Pfizer Inc. provides pharmaceutical products for the management of hyperthyroidism, including Graves' Disease.
- **Abbott Laboratories**: Abbott Laboratories is known for its diagnostic tests and devices used in the diagnosis and monitoring of thyroid disorders like Graves' Disease.
- **Novartis AG**: Novartis AG is involved in the research and development of innovative treatments for autoimmune diseases, including those affecting the thyroid gland.
- **Sanofi**: Sanofi offers a range of medications and therapies for endocrine disorders, including Graves' Disease, contributing significantly to the market.
The Graves' Disease (Overactive Thyroid) market is witnessing growth due to factors such as increasing prevalence of thyroid disorders, advancements in diagnostic technology, and rising awareness about hyperthyroidism among the global population. The rising geriatric population, who are more prone to thyroid disorders, is also a key driver for market growth. Additionally, the availability of various treatment options, ranging from medication to surgical interventions, is expanding the market further.
On the basis of diagnosis type, blood tests play a crucial role in detecting Graves' Disease by measuringThe Graves' Disease market is characterized by a variety of diagnosis techniques, predominantly blood tests, imaging tests, and uptake scans. Blood tests are commonly used to measure levels of thyroid hormones and antibodies associated with Graves' Disease. Imaging tests like ultrasound or CT scans help visualize the size and condition of the thyroid gland, while uptake scans assess thyroid function by tracking the absorption of a radioactive substance. The significance of accurate diagnosis cannot be overstated in effectively managing Graves' Disease, as it informs the selection of appropriate treatment options and monitoring of the condition.
When it comes to treatment options, the Graves' Disease market offers a range of interventions tailored to individual patient needs. Medication therapy, such as antithyroid drugs or beta-blockers, aims to regulate thyroid hormone levels and alleviate symptoms. Radioactive iodine therapy involves the administration of radioactive iodine to destroy thyroid tissue, particularly useful in cases of persistent hyperthyroidism. For some patients, surgical removal of part or all of the thyroid gland may be necessary to address severe symptoms or complications. The availability of diverse treatment modalities underscores the importance of personalized care in managing Graves' Disease effectively.
In terms of end-users, the market caters to various healthcare facilities and providers involved in diagnosing and treating Graves' Disease. Hospitals serve as primary centers for acute care and inpatient services, offering comprehensive treatment options for patients with severe symptoms or complications. Specialty clinics often provide specialized care for endocrine disorders like Graves' Disease, including access to endocrinologists and advanced treatment modalities. Diagnostic centers play a vital role in conducting tests and imaging studies to confirm the diagnosis and monitor disease progression. Retail pharmacies are essential for dispensing medications prescribed for Graves' Disease management, ensuring patients have access to necessary treatments conveniently.
Market players in the Graves' Disease segment play a crucial role in driving innovation, research, and development of new therapies and diagnostic tools. Leading companies like Merck & Co., Inc., Pfizer Inc., Abbott Laboratories, Novartis AG,**Global Graves' Disease (Overactive Thyroid) Market, By Diagnosis (Radioactive Iodine Uptake, Imaging Tests, Blood Tests, Others), Treatment (Radioactive iodine therapy, Medication, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029**
The global Graves' Disease market is poised for substantial growth driven by several key factors. The increasing prevalence of thyroid disorders, including Graves' Disease, is a primary driver for market expansion. As awareness about hyperthyroidism grows among the global population, more individuals are seeking diagnosis and treatment, stimulating market demand. The aging population, who are at higher risk of thyroid disorders, further fuels market growth. Technological advancements in diagnostic tools, such as blood tests, imaging tests, and uptake scans, are also contributing to the market's development by improving the accuracy and efficiency of diagnosis.
Treatment options for Graves' Disease, ranging from medication therapy to surgical interventions, offer patients a variety of choices tailored to their specific needs. Medication therapy using antithyroid drugs or beta-blockers aims to regulate thyroid hormone levels and manage symptoms effectively. Radioactive iodine therapy, a common treatment for hyperthyroidism, involves the controlled administration of radioactive iodine to target and reduce thyroid activity. In cases where medication
Graves' Disease (Overactive Thyroid) Key Benefits over Global Competitors:
- The report provides a qualitative and quantitative analysis of the Graves' Disease (Overactive Thyroid) Market trends, forecasts, and market size to determine new opportunities.
- Porter’s Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make strategic business decisions and determine the level of competition in the industry.
- Top impacting factors & major investment pockets are highlighted in the research.
- The major countries in each region are analyzed and their revenue contribution is mentioned.
- The market player positioning segment provides an understanding of the current position of the market players active in the Personal Care Ingredients
Table of Contents: Graves' Disease (Overactive Thyroid) Market
1 Introduction
2 Global Graves' Disease (Overactive Thyroid) Market Segmentation
3 Executive Summary
4 Premium Insight
5 Market Overview
6 Graves' Disease (Overactive Thyroid) Market, by Product Type
7 Graves' Disease (Overactive Thyroid) Market, by Modality
8 Graves' Disease (Overactive Thyroid) Market, by Type
9 Graves' Disease (Overactive Thyroid) Market, by Mode
10 Graves' Disease (Overactive Thyroid) Market, by End User
12 Graves' Disease (Overactive Thyroid) Market, by Geography
12 Graves' Disease (Overactive Thyroid) Market, Company Landscape
13 Swot Analysis
14 Company Profiles
Critical Insights Related to the Graves' Disease (Overactive Thyroid) Included in the Report:
- Exclusive graphics and Illustrative Porter’s Five Forces analysis of some of the leading companies in this market
- Value chain analysis of prominent players in the market
- Current trends influencing the dynamics of this market across various geographies
- Recent mergers, acquisitions, collaborations, and partnerships
- Revenue growth of this industry over the forecast period
- Marketing strategy study and growth trends
- Growth-driven factor analysis
- Emerging recess segments and region-wise market
- An empirical evaluation of the curve of this market
- Ancient, Present, and Probable scope of the market from both prospect value and volume
Browse Trending Reports:
Mouth Freshener Market
Biological Molluscicides Market
Traffic Management Market
Sexual Wellness Market
Organic Poultry Feed Market
Gammaretroviral Vector Market
Infrastructure Inspection Market
Scented Candle Market
Cloud Backup Market
Online Testing Software Market
Real Time Parking System Market
Mobile Cases And Covers Market
Toxic Epidermal Necrolysis Market
Weather Monitoring Solutions And Services Market
Electronic Records Management Solutions Market
Seed Coating Colorants Market
Huntingtons Disease Treatment Market
Specimen Collection Kit Market
Finished Lubricant Market
Specimen Validity Testing Market
Immunoprotein Diagnostic Testing Market
Satellite Transponder Market
Building Thermal Insulation Market
Broadband Internet Access Services Market
Microalgae In Feed Market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek